Ayalew Tefferi

Ayalew Tefferi

UNVERIFIED PROFILE

Are you Ayalew Tefferi?   Register this Author

Register author
Ayalew Tefferi

Ayalew Tefferi

Publications by authors named "Ayalew Tefferi"

Are you Ayalew Tefferi?   Register this Author

100Publications

1594Reads

7Profile Views

WHO defined chronic eosinophilic leukemia, not otherwise specified (CEL, NOS): A contemporary series from the Mayo Clinic.

Am J Hematol 2020 Jul 17;95(7):E172-E174. Epub 2020 Apr 17.

Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25811DOI Listing
July 2020

Erythrocytosis associated with cerebral hemangiomas and multiple venous anomalies.

Am J Hematol 2020 Jun 29. Epub 2020 Jun 29.

Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25913DOI Listing
June 2020

Pregnancy outcomes in myeloproliferative neoplasms: A Mayo Clinic report on 102 pregnancies.

Am J Hematol 2020 05 17;95(5):E114-E117. Epub 2020 Feb 17.

Division of Hematology, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25748DOI Listing
May 2020

Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera.

Br J Haematol 2020 Apr 16;189(2):291-302. Epub 2020 Jan 16.

Department of Experimental and Clinical Medicine, CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, and Denothe Excellence Center, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16380DOI Listing
April 2020

Essential Thrombocythemia. Reply.

N Engl J Med 2020 03;382(12):e21

Mayo Clinic, Rochester, MN

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1917586DOI Listing
March 2020

Myelofibrosis biology and contemporary management.

Br J Haematol 2020 Mar 20. Epub 2020 Mar 20.

Division of Hematology, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16576DOI Listing
March 2020

Chronic neutrophilic leukemia: 2020 update on diagnosis, molecular genetics, prognosis, and management.

Am J Hematol 2020 02 30;95(2):212-224. Epub 2019 Dec 30.

Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25688DOI Listing
February 2020

The new WHO classification for essential thrombocythemia calls for revision of available evidences.

Blood Cancer J 2020 02 25;10(2):22. Epub 2020 Feb 25.

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41408-020-0290-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042222PMC
February 2020

Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management.

Am J Hematol 2020 01;95(1):97-115

Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25684DOI Listing
January 2020

Essential Thrombocythemia.

N Engl J Med 2019 11;381(22):2135-2144

From the Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMcp1816082DOI Listing
November 2019

Cytogenetic clonal evolution in myeloproliferative neoplasms: contexts and prognostic impact among 648 patients with serial bone marrow biopsies.

Leukemia 2019 10 1;33(10):2522-2553. Epub 2019 May 1.

Divisions of Laboratory Genetics and Genomics, Departments of Internal Medicine and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-019-0453-5DOI Listing
October 2019

Atypical Phenotype and Treatment Response Pattern in a Patient with FIP1L1-PDGFRα Mutation.

Acta Haematol 2018 5;140(2):67-70. Epub 2018 Sep 5.

Mayo Clinic, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000492485DOI Listing
June 2019

Mutations and prognosis in myeloproliferative neoplasms.

Leuk Lymphoma 2019 05 14;60(5):1112-1113. Epub 2018 Nov 14.

a Division of Hematology, Department of Internal Medicine , Mayo Clinic , Rochester , MN , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2018.1537490DOI Listing
May 2019

Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis: "2019 Update on Diagnosis, Risk-stratification, and Management".

Am J Hematol 2019 04 24;94(4):475-488. Epub 2019 Jan 24.

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.25397
Publisher Site
http://dx.doi.org/10.1002/ajh.25397DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408294PMC
April 2019

Calculator-free point-of-care prognostication in myelodysplastic syndromes.

Am J Hematol 2019 04 24;94(4):E99-E101. Epub 2019 Jan 24.

Divisions of Hematology, Departments of Internal and Laboratory Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.25400
Publisher Site
http://dx.doi.org/10.1002/ajh.25400DOI Listing
April 2019

Determinants of long-term outcome in type 1 calreticulin-mutated myelofibrosis.

Leukemia 2019 03 12;33(3):780-785. Epub 2018 Oct 12.

Divisions of Hematology, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0283-xDOI Listing
March 2019

World Health Organization class-independent risk categorization in mastocytosis.

Blood Cancer J 2019 03 4;9(3):29. Epub 2019 Mar 4.

Divisions of Hematology, Departments of Internal Medicine and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41408-019-0189-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399221PMC
March 2019

Smoldering mastocytosis: Survival comparisons with indolent and aggressive mastocytosis.

Am J Hematol 2019 01 9;94(1):E1-E2. Epub 2018 Nov 9.

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.25302
Publisher Site
http://dx.doi.org/10.1002/ajh.25302DOI Listing
January 2019

Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management.

Am J Hematol 2019 01 9;94(1):133-143. Epub 2018 Nov 9.

Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25303DOI Listing
January 2019

Primary myelofibrosis: 2019 update on diagnosis, risk-stratification and management.

Authors:
Ayalew Tefferi

Am J Hematol 2018 12 26;93(12):1551-1560. Epub 2018 Oct 26.

Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.25230
Publisher Site
http://dx.doi.org/10.1002/ajh.25230DOI Listing
December 2018

Practice-relevant demarcation of systemic mastocytosis associated with another hematologic neoplasm.

Am J Hematol 2018 12 17;93(12):E383-E386. Epub 2018 Oct 17.

Divisions of Hematology, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25269DOI Listing
December 2018

Myeloproliferative neoplasms in the young: Mayo Clinic experience with 361 patients age 40 years or younger.

Am J Hematol 2018 12 27;93(12):1474-1484. Epub 2018 Sep 27.

Divisions of Hematology, Departments of Internal and Laboratory Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25270DOI Listing
December 2018

Mutations and karyotype predict treatment response in myelodysplastic syndromes.

Am J Hematol 2018 11 30;93(11):1420-1426. Epub 2018 Sep 30.

Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25267DOI Listing
November 2018

Genetic predictors of response to specific drugs in primary myelofibrosis.

Blood Cancer J 2018 11 19;8(12):120. Epub 2018 Nov 19.

Divisions of Hematology, Departments of Internal Medicine and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41408-018-0158-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6242902PMC
November 2018

MPL-mutated essential thrombocythemia: a morphologic reappraisal.

Blood Cancer J 2018 11 20;8(12):121. Epub 2018 Nov 20.

Division of Hematology, Departments of Internal and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41408-018-0159-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6246562PMC
November 2018

U2AF1 mutation types in primary myelofibrosis: phenotypic and prognostic distinctions.

Leukemia 2018 10 27;32(10):2274-2278. Epub 2018 Feb 27.

Division of Hematology, Departments of Medicine and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0078-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170397PMC
October 2018

Upfront low-dose ponatinib (15 mg/day) for multi-TKI resistant chronic myeloid leukemia.

Authors:
Ayalew Tefferi

Hematol Oncol 2018 Oct 14;36(4):718-720. Epub 2018 Jun 14.

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2517DOI Listing
October 2018

Early thrombotic events and preemptive systemic anticoagulation following splenectomy for myelofibrosis.

Am J Hematol 2018 09 31;93(9):E235-E238. Epub 2018 Aug 31.

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25203DOI Listing
September 2018

Blast-phase chronic myelomonocytic leukemia: more than just semantics.

Leukemia 2018 09 7;32(9):2093-2094. Epub 2018 Aug 7.

MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0228-4DOI Listing
September 2018

Chronic neutrophilic leukemia: 2018 update on diagnosis, molecular genetics and management.

Am J Hematol 2018 08;93(4):578-587

Department of Internal Medicine, Division of Hematology, Mayo Clinic College of Medicine, 200 First St. SW, Rochester, Minnesota, 55905.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24983DOI Listing
August 2018

How I treat myelofibrosis after failure of JAK inhibitors.

Blood 2018 08 4;132(5):492-500. Epub 2018 Jun 4.

Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2018-02-785923DOI Listing
August 2018

GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis.

Leukemia 2018 07 23;32(7):1631-1642. Epub 2018 Mar 23.

Department of Experimental and Clinical Medicine, CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0107-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035151PMC
July 2018

The impact of sex on disease phenotype and prognostic thresholds of anemia in myelodysplastic syndromes.

Am J Hematol 2018 07 6;93(7):E164-E167. Epub 2018 May 6.

Divisions of Hematology, Departments of Internal and Laboratory Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25114DOI Listing
July 2018

Myelofibrosis Treatment Algorithm 2018.

Blood Cancer J 2018 07 31;8(8):72. Epub 2018 Jul 31.

Department of Experimental and Clinical Medicine, CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41408-018-0109-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068139PMC
July 2018

U2AF1 mutation variants in myelodysplastic syndromes and their clinical correlates.

Am J Hematol 2018 Jun 6;93(6):E146-E148. Epub 2018 Apr 6.

Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25084DOI Listing
June 2018

MIPSS70+ Version 2.0: Mutation and Karyotype-Enhanced International Prognostic Scoring System for Primary Myelofibrosis.

J Clin Oncol 2018 06 30;36(17):1769-1770. Epub 2018 Apr 30.

Ayalew Tefferi, Mayo Clinic, Rochester, MN; Paola Guglielmelli, University of Florence, Florence, Italy; Terra L. Lasho, Naseema Gangat, Rhett P. Ketterling, and Animesh Pardanani, Mayo Clinic, Rochester, MN; and Alessandro M. Vannucchi, University of Florence, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.9867DOI Listing
June 2018

Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management.

Am J Hematol 2018 06;93(6):824-840

Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.25104
Publisher Site
http://dx.doi.org/10.1002/ajh.25104DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995129PMC
June 2018

Validation of the WHO-defined 20% circulating blasts threshold for diagnosis of leukemic transformation in primary myelofibrosis.

Blood Cancer J 2018 06 11;8(6):57. Epub 2018 Jun 11.

Department of Internal Medicine and Laboratory Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41408-018-0095-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996023PMC
June 2018

Mayo CALR mutation type classification guide using alpha helix propensity.

Am J Hematol 2018 05 24;93(5):E128-E129. Epub 2018 Feb 24.

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25065DOI Listing
May 2018

Prevention of liver cancer with new curative hepatitis C antivirals: Real-world challenges.

Cancer 2018 04 27;124(8):1647-1649. Epub 2018 Feb 27.

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31291DOI Listing
April 2018

Chronic neutrophilic leukemia: new science and new diagnostic criteria.

Blood Cancer J 2018 02 13;8(2):19. Epub 2018 Feb 13.

Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41408-018-0049-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811432PMC
February 2018